Copyright
©The Author(s) 2017.
World J Gastroenterol. Dec 21, 2017; 23(47): 8345-8354
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8345
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8345
Table 6 Correlation between circ-LDLRAD3 expression and clinicopathological factors of pancreatic cancer patients (ΔCT values in plasma samples)
| Variable | Circ-LDLRAD3 expression level | |
| Spearman correlation | P value | |
| Age (yr) | -0.108 | 0.562 |
| Gender | 0.059 | 0.752 |
| Tumor diameter (cm) | -0.102 | 0.584 |
| CA19-9 | -0.398 | 0.027 |
| CEA | -0.085 | 0.650 |
| Clinical stage | -0.603 | < 0.001 |
| T classification | -0.129 | 0.491 |
| N classification | -0.271 | 0.140 |
| Metastasis | -0.5 | 0.004 |
| Venous invasion | -0.392 | 0.029 |
| Lymphatic invasion | -0.611 | < 0.001 |
- Citation: Yang F, Liu DY, Guo JT, Ge N, Zhu P, Liu X, Wang S, Wang GX, Sun SY. Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. World J Gastroenterol 2017; 23(47): 8345-8354
- URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8345.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i47.8345